Sanctuary Advisors LLC acquired a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 370,246 shares of the company’s stock, valued at approximately $47,577,000. Sanctuary Advisors LLC owned 0.29% of Merck KGaA as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in MKGAF. Frazier Financial Advisors LLC bought a new position in shares of Merck KGaA during the 2nd quarter valued at approximately $25,000. Rakuten Securities Inc. bought a new stake in shares of Merck KGaA in the 2nd quarter worth approximately $27,000. Solstein Capital LLC purchased a new position in Merck KGaA in the second quarter valued at approximately $33,000. Burk Holdings LLC purchased a new position in Merck KGaA in the second quarter valued at approximately $39,000. Finally, Bard Associates Inc. bought a new position in Merck KGaA during the second quarter valued at $60,000. 0.10% of the stock is currently owned by hedge funds and other institutional investors.
Merck KGaA Price Performance
Shares of OTCMKTS MKGAF opened at $163.21 on Monday. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The stock has a fifty day simple moving average of $162.62 and a two-hundred day simple moving average of $148.44. Merck KGaA has a 1-year low of $116.68 and a 1-year high of $175.56. The firm has a market cap of $21.09 billion, a price-to-earnings ratio of 24.92 and a beta of 0.96.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
